genO-hCD3ε Humanized Mouse

The genO‑hCD3ε immunocompetent mice enable the preclinical in vivo efficacy assessment of T-cell engagers, to study cancer cell recognition, immunosuppressant therapies, etc.

  Application Areas: 

Model No.NomenclatureGenotype
23515-MC57BL/6N-Cd3eem1.1(CD3E)Genohu/hu
23515-FC57BL/6N-Cd3eem1.1(CD3E)Genohu/hu

Availability Notice: genOway target-specific humanized models are available from Taconic exclusively for U.S.-based customers.


Evaluate a New Humanized Model with Special Pilot Cohort Pricing

Considering a target-specific humanized mouse model for your next study? Special pilot cohort pricing makes it easier to evaluate a new model in your experimental setting before incorporating it into a broader program study.

For-profit customers can save 30-60% on your first cohort of an eligible genOway model, with an additional 20% discount available for mixed-sex cohorts.

View:
Select One

Overview

Nomenclature: C57BL/6N-Cd3eem1.1(CD3E)Geno

Applications: Assess efficacy of T-cell engagers targeting the CD3 SP34 epitope, including tumor-growth inhibition; perform long-term studies of immunological memory after treatment; assess anti-CD3-induced cytokine release syndrome (CRS) risk.

Features: Conserved interaction with CD3γ, CD3δ and CD3ζ subunits; physiological humanized CD3 expression; functional T/B-cell cooperation; fully functional mouse immune system.

Origin

This model was generated by genOway S.A.

Orders by weight: Taconic cannot accept orders by weight for this model. Please note that shipments may contain animals with a larger weight variation. 

Genetics

Species: Mouse
Strain Type: Inbred
Allele Type: Genetically Humanized
Coat Color: Black
Genetic Background: C57BL/6N

Guides & Publications

Initial Publication: 

  • Zorn JA, Wheeler ML, Barnes RM, Kaberna J, Morishige W, Harris M, Huang RY, Lohre J, Chang YC, Chau B, Powers K, Schindler I, Neradugomma N, Thomas W, Liao X, Zhou Y, West SM, Wang F, Kotapati S, Chen G, Yamazoe S, Kosenko A, Dollinger G, Sproul T, Rajpal A, Strop P. Humanization of a strategic CD3 epitope enables evaluation of clinical T-cell engagers in a fully immunocompetent in vivo model. Sci Rep. 2022 Mar 3;12(1):3530.

Applications & Therapeutic Areas

  • Oncology & Immuno-Oncology
  • Immunology

Transit, Housing & Welfare

Need more info? Click the live chat button or Contact Us

Licensing

Click here to download the General Conditions of Sale for genOway models.

View the production locations(s) and the accompanying current IHMS™ Health Report and Taconic Health Standard for this model

Schedule A Scientific Consultation

Connect directly with a member of our Scientific Solutions team who can help you select the most appropriate model and maximize your experimental success.

Related Models

Click here to view related models.

Oncology & Immuno-Oncology Portfolio

Target-Specific Humanized Mice

Explore target-specific genOway humanized mouse models available through Taconic for oncology drug discovery and translational research in the United States.

Collaborate with Us to Advance Your Immuno-Oncology Research